arrow
D

Dominic P. Williams

glaxosmithkline
H指数:53
被引数:8,889

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

超越NAMs与动物模型:使用情境作为药物开发中综合非临床策略的指导框架

2026-09-010
PRE
Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug discovery

凋亡标志物能够实现药物诱导性肝损伤的早期和快速筛查,以加速药物发现。

2025-12-240
OAAI
Industry Perspective on Nonclinical Approaches for Hepatotoxicity Risk Assessment: Insights from Two Longitudinal Surveys Conducted in 2023 and 2017

行业视角下非临床方法用于肝毒性风险评估:来自2023年和2017年两项纵向调查的见解

2025-10-130
PRE
Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World

基于化学结构的毒性预测机器学习:现实世界成功的基石

2025-05-020
OA
The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds
2022-01-0119
OAAI
In silico approaches in organ toxicity hazard assessment: Current status and future needs in predicting liver toxicity
2021-11-0122
OAAI
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

管理药物性肝损伤的挑战: 开发和部署临床前预测模型的路线图

2019-11-20156
OAAI